{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T23:29:49Z","timestamp":1790206189257,"version":"4.1.0"},"reference-count":46,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2014,2,26]],"date-time":"2014-02-26T00:00:00Z","timestamp":1393372800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0089088","type":"journal-article","created":{"date-parts":[[2014,2,26]],"date-time":"2014-02-26T21:53:40Z","timestamp":1393451620000},"page":"e89088","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":26,"title":["Effects of Switching from Stavudine to Raltegravir on Subcutaneous Adipose Tissue in HIV-Infected Patients with HIV\/HAART-Associated Lipodystrophy Syndrome (HALS). A Clinical and Molecular Study"],"prefix":"10.1371","volume":"9","author":[{"given":"Pere","family":"Domingo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda del Mar","family":"Gutierrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Miguel","family":"Gallego-Escuredo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferran","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gracia Mar\u00eda","family":"Mateo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Villarroya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"de los Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan Carles","family":"Domingo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesc","family":"Villarroya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Del","family":"Rio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente","family":"Estrada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Giralt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,2,26]]},"reference":[{"key":"ref1","unstructured":"Domingo P, Estrada V, L\u00f3pez-Aldeguer J, Villarroya F, Mart\u00ednez E (2012) Fat redistribution syndromes associated with HIV-1 infection and combination antiretroviral therapy. AIDS Rev: 112\u2013123."},{"key":"ref2","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.2174\/138161210793563482","article-title":"Impact of mitochondrial toxicity of HIV-1 antiretroviral drugs on lipodystrophy and metabolic dysregulation","volume":"16","author":"ER Feeney","year":"2010","journal-title":"Curr Pharm Des"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1517\/14656566.8.12.1871","article-title":"Strategies in the treatment of HIV-1-associated adipose redistribution syndromes","volume":"8","author":"MM Gutierrez","year":"2007","journal-title":"Expert Opin Pharmacother"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1001\/jama.288.2.207","article-title":"Abacavir substitution for nucleoside analogs in patients with HIV lipoatrophy: a randomized trial","volume":"288","author":"A Carr","year":"2002","journal-title":"JAMA"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1097\/01.aids.0000247574.33998.03","article-title":"A randomized comparative trial of tenofovir DF or abacavir as replacement for a thymidine analogue in persons with lipoatrophy","volume":"20","author":"GJ Moyle","year":"2006","journal-title":"AIDS"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1093\/cid\/cir510","article-title":"Long-term treatment with raltegravir or efavirenz combined with tenofovir\/emtricitabine for treatment-naive human immunodeficiency virus-1-infected patients: 156-week results from STARTMRK","volume":"53","author":"JK Rockstroh","year":"2011","journal-title":"Clin Infect Dis"},{"key":"ref7","first-page":"1","article-title":"1993 revised classification system for HIV infection and expanded surveillance for case definition for AIDS among adolescents and adults","volume":"(RR-17)","year":"1993","journal-title":"MMWR 41"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1093\/ajcn\/64.5.685","article-title":"A single threshold of waist girth identifies normal-weight and overweight subjects with excess visceral adipose tissue","volume":"64","author":"S Lemieux","year":"1996","journal-title":"Am J Clin Nutr"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1385\/JCD:8:3:287","article-title":"Total body composition by DXA of 241 HIV-negative men and 162 HIV-infected men: proposal of reference values for defining lipodystrophy","volume":"8","author":"E Bonnet","year":"2005","journal-title":"J Clin Densitom"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"e7038","DOI":"10.1371\/journal.pone.0007038","article-title":"Dual energy X-Ray absorptiometry body composition reference values from NHANES","volume":"4","author":"TL Kelly","year":"2009","journal-title":"PLoS One"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1177\/135965350300800614","article-title":"Contribution of nucleoside analogue reverse transcriptase inhibitor therapy to lipoatrophy from the population to the cellular level","volume":"8","author":"D Nolan","year":"2003","journal-title":"Antivir Ther"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1097\/00002030-200107270-00008","article-title":"Clinical assessment of HIV-associated lipodystrophy in an ambulatory population","volume":"15","author":"KA Lichtenstein","year":"2001","journal-title":"AIDS"},{"key":"ref13","first-page":"L28","article-title":"A practical classification for the surgical filling of facial lipoatrophy","volume":"10","author":"J Fontdevila","year":"2005","journal-title":"Antivir Ther"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive Summary of the Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","article-title":"Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute Scientific Statement","volume":"112","author":"SM Grundy","year":"2005","journal-title":"Circulation"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/clinchem\/41.5.717","article-title":"Direct measurement of high-density lipoprotein cholesterol in serum with polyethylene glycol-modified enzymes and sulphated alpha-cyclodextrin","volume":"41","author":"H Sugiuchi","year":"1995","journal-title":"Clin Chem"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment","volume":"28","author":"DR Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.mito.2011.01.011","article-title":"Quality assessment of human mitochondrial DNA quantification: MITONAUTS, an international multicentre survey","volume":"11","author":"HC C\u00f4t\u00e9","year":"2011","journal-title":"Mitochondrion"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/QAI.0b013e31802bf122","article-title":"Less lipoatrophy and better lipid profile with abacavir as compared to stavudine: 96-week results of a randomized study","volume":"44","author":"D Podzamczer","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1001\/jama.292.2.191","article-title":"Efficacy and safety of tenofovir DF vsstavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial","volume":"292","author":"JE Gallant","year":"2004","journal-title":"JAMA"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1093\/infdis\/jis720","article-title":"Changes in fat mitochondrial DNA and function in subjects randomized to abacavir-lamivudine or tenofovir DF-emtricitabine with atazanavir-ritonavir or efavirenz: AIDS Clinical Trials Group study A5224s, substudy of A5202","volume":"207","author":"GA McComsey","year":"2013","journal-title":"J Infect Dis"},{"key":"ref22","unstructured":"Mulligan K, Glidden DV, Lama JR, Chariyalertsak S, Guanira-Carranza JV, et al. Effects of Tenofovir\/Emtricitabine on body composition in HIV-negative men who have sex with men: whole body DXA results of global iPRex. 19<sup>th<\/sup> Conference on Retroviruses and Opportunistic Infections. Seattle, March 5\u20138, 2012. Abstract 47: 847."},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1177\/135965350701200704","article-title":"Mitochondrial toxicity of tenofovir, emtricitabine and abacavir alone and in combination with additional nucleoside reverse transcriptase inhibitors","volume":"12","author":"N Venhoff","year":"2007","journal-title":"Antivir Ther"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1468-1293.2012.01004.x","article-title":"Body fat distribution in HIV-infected patients treated for 96 weeks with darunavir\/ritonavir monotherapy versus darunavir\/ritonavir plus nucleoside reverse transcriptase inhibitors: the MONOI-ANRS136 Substudy","volume":"13","author":"M Valantin","year":"2012","journal-title":"HIV Med"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/ki.2010.344","article-title":"Tenofovir-induced kidney disease: an acquired renal tubular mitochondriopathy","volume":"78","author":"MA Perazella","year":"2010","journal-title":"Kidney Int"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/00002030-199006000-00006","article-title":"Mellert W, Kleinschmidt A, Schmidt J, Festl H, Emler S, et al. Infection of human fibroblasts and osteoblast-like cells with HIV-1","volume":"4","journal-title":"AIDS"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"545","DOI":"10.2174\/157016210793499222","article-title":"Differential effects of efavirenz and lopinavir\/ritonavir on human adipocyte differentiation, gene expression and release of adipokines and pro-inflammatory cytokines","volume":"8","author":"JM Gallego-Escuredo","year":"2010","journal-title":"Curr HIV Res"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/135965350801300103","article-title":"Contribution of mitochondrial dysfunction and oxidative stress to cellular premature senescence induced by antiretroviral thymidine analogues","volume":"13","author":"M Caron","year":"2008","journal-title":"Antivir Ther"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1310\/hct1302-103","article-title":"Longer prior exposure to zidovudine\/lamivudine-containing combination antiretroviral therapy, age, and male gender are each associated with reduced subcutaneous adipose tissue","volume":"13","author":"SM Vrouenraets","year":"2012","journal-title":"HIV Clin Trials"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S0140-6736(09)62041-9","article-title":"Switch to a raltegravir-based regimenn versus continuation of a lopinavir-ritonavir-based regimenn in stable HIV-infected patients with suppressed viraemia (SWITCHMRK 1 and 2): two multicentre, double-blind, randomised controlled trials","volume":"375","author":"JJ Eron","year":"2010","journal-title":"Lancet"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1097\/QAD.0b013e32833a608a","article-title":"Substitution of raltegravir for ritonavir-boosted protease inhibitors in HIV-infected patients: the SPIRAL study","volume":"24","author":"E Mart\u00ednez","year":"2010","journal-title":"AIDS"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/QAD.0b013e32834f3507","article-title":"Body composition changes after switching from protease inhibitors to raltegravir: SPIRAL-LIP substudy","volume":"26","author":"A Curran","year":"2012","journal-title":"AIDS"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1086\/496981","article-title":"The relationship between nucleoside analogue treatment duration, insulin resistance, and fasting arterialized lactate level in patients with HIV infection","volume":"41","author":"JC Lo","year":"2005","journal-title":"Clin Infect Dis"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1086\/381783","article-title":"Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: are different antiretroviral drugs associated with different lipid profiles","volume":"189","author":"E Fontas","year":"2004","journal-title":"J Infect Dis"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.tips.2004.12.005","article-title":"Lipodystrophy associated with highly active anti-retroviral therapy for HIV infection: the adipocyte as a target of anti-retroviral-induced mitochondrial toxicity","volume":"26","author":"F Villarroya","year":"2005","journal-title":"Trends Pharmacol Sci"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.beem.2010.12.001","article-title":"Adipose tissue biology and HIV-infection","volume":"25","author":"M Giralt","year":"2011","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1097\/00002030-200411050-00004","article-title":"The HIV-1 nucleoside reverse transcriptase inhibitors stavudine and zidovudine alter adipocyte functions in vitro","volume":"18","author":"M Caron","year":"2004","journal-title":"AIDS"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/01.qai.0000187443.30838.3e","article-title":"Assessment of adipokine expression and mitochondrial toxicity in HIV patients with lipoatrophy on stavudine- and zidovudine-containing regimens","volume":"40","author":"SP Jones","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1177\/135965350701200407","article-title":"Some HIV-antiretrovirals increase oxidative stress and alter chemokine, cytokine or adiponectin production in human adipocytes and macrophages","volume":"12","author":"C Lagathu","year":"2007","journal-title":"Antivir Ther"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1177\/135965350701200206","article-title":"Relationship of mitochondrial DNA depletion and respiratory chain activity in preadipocytes treated with nucleoside reverse transcriptase inhibitors","volume":"12","author":"MV Stankov","year":"2007","journal-title":"Antivir Ther"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"174","DOI":"10.2174\/157016211795945278","article-title":"Neutral actions of raltegravir on adipogenesis, glucose metabolism and lipolysis in 3T3-L1 adipocytes","volume":"9","author":"P Perez-Matute","year":"2011","journal-title":"Curr HIV Res"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s10156-010-0101-5","article-title":"Comparison of the influence of four classes of HIV antiretrovirals on adipogenic differentiation: the minimal effect of raltegravir and atazanavir","volume":"17","author":"R Minami","year":"2011","journal-title":"J Infect Chemother"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1086\/593179","article-title":"Effect of rosiglitazone on peroxisome proliferator-activated receptor gamma gene expression in human adipose tissue is limited by antiretroviral drug-induced mitochondrial dysfunction","volume":"198","author":"PW Mallon","year":"2008","journal-title":"J Infect Dis"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1177\/135965350701200809","article-title":"A 6-month interruption of antiretroviral therapy improves adipose tissue function in HIV-infected patients: the ANRS EP29 Lipostop Study","volume":"12","author":"MJ Kim","year":"2007","journal-title":"Antivir Ther"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/oby.2010.230","article-title":"Systemic effects of white adipose tissue dysregulation and obesity-related inflammation","volume":"19","author":"AJ Guri","year":"2011","journal-title":"Obesity (Silver Spring)"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"e1001240","DOI":"10.1371\/journal.pmed.1001240","article-title":"The Ethics of Switch\/Simplify in Antiretroviral Trials: Non-Inferior or Just Inferior","volume":"9","author":"A Carr","year":"2012","journal-title":"PLoS Med"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0089088","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T16:37:37Z","timestamp":1716568657000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0089088"}},"subtitle":[],"editor":[{"given":"Alan","family":"Landay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,2,26]]},"references-count":46,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2014,2,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0089088","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,26]]}}}